
|Articles|June 1, 2005
- Pharmaceutical Technology-06-01-2005
- Volume 205 Supplement
- Issue 3
The Part 11 Controversy: A Root Cause Analysis and Science-Based Solutions
The confusion surrounding the application of 21 CFR Part 11 can be solved by focusing on the common rationale that both protects the public health and drives the fundamental basis of the industry's business: good science.
Advertisement
Articles in this issue
over 21 years ago
Electronic Records Management Practices and Part 11over 21 years ago
Glossary of termsover 21 years ago
Electronic Records Management Practices and Part 11Tamar M. JuneAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
5




